Original paper
Bevacizumab and folic acid dual-targeted gadolinium-carbon dots for fluorescence/magnetic resonance imaging of hepatocellular carcinoma
Volume: 61, Pages: 102288 - 102288
Published: Feb 1, 2021
Abstract
In this study, single- and dual-targeted gadolinium-carbon dots (Gd-CDs) with Bevacizumab (BEV) and/or folic acid (FA) were developed as dual-modal fluorescence and magnetic resonance (FL/MR) imaging nanoprobes. Gd-CDs were prepared by a single-pot hydrothermal route using citric acid, ethylenediamine, and Gd-DO3A-butrol (Gadovist) as the starting materials. Mouse hepatocellular carcinoma (Hepa1-6) cell line was selected as cancer cells, while...
Paper Details
Title
Bevacizumab and folic acid dual-targeted gadolinium-carbon dots for fluorescence/magnetic resonance imaging of hepatocellular carcinoma
Published Date
Feb 1, 2021
Volume
61
Pages
102288 - 102288
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History